Breaking News Instant updates and real-time market news.

SNAP

Snap

$14.00

-0.58 (-3.98%)

07:44
10/23/19
10/23
07:44
10/23/19
07:44

JPMorgan upgrades 'increasingly compelling' Snap to Overweight from Neutral

JPMorgan analyst Doug Anmuth upgraded Snap to Overweight from Neutral with a price target of $20, up from $17. The stock in premarket trading is up 2% to $14.33. Following a 20% pullback from recent highs and last night's Q3 results that "showed more encouraging trends," Snap shares are "increasingly compelling," Anmuth tells investors in a research note. The analyst believes Snap's platform and business have both "improved dramatically over the past several quarters." Daily active users have now increased for three straight quarters, accelerating to 13% growth in Q3, while daily time spent continues to run at 30-plus minutes per user, Anmuth points out. Further, the analyst thinks Snap is at an "inflection point" with positive EBITDA for the first time in Q4.

  • 21

    Nov

SNAP Snap
$14.00

-0.58 (-3.98%)

10/23/19
STFL
10/23/19
NO CHANGE
Target $19
STFL
Buy
Stifel says 'don't be spooked,' Snap momentum remains intact
Snap reported upside to revenue, daily active users and adjusted EBITDA in Q3 and its outlook for Q4 met Street expectations, Stifel analyst John Egbert tells investors in a post-earnings research note titled "Don't Be Spooked; Audience Growth, Advertising Momentum, and Operating Leverage Remain Intact." The analyst sees a "clear path" to sustained profitability for Snap despite ongoing investments in sales, content, and longer-term platform and wearable computing initiatives. He reiterates a Buy rating on the shares with an unchanged price target of $19.
10/23/19
RSBL
10/23/19
NO CHANGE
Target $21
RSBL
Buy
Snap shares should be bought on post-earnings weakness, says Rosenblatt
Rosenblatt analyst Mark Zgutowicz reiterates his Buy rating and $21 price target on shares of Snap following the company's Q3 report, stating that he would be a buyer on any weakness in the shares today. Snap's outlook remains "stellar" in terms of both product and demand and he suspects the company's Q4 guidance will prove conservative, Zgutowicz tells investors. Beyond the upcoming holiday quarter, management remains focused on executing and he predicts "a long consistent trajectory ahead," the analyst added.
10/23/19
NEED
10/23/19
UPGRADE
NEED
Hold
Snap upgraded to Hold from Underperform at Needham
10/23/19
NEED
10/23/19
UPGRADE
NEED
Hold
Snap upgraded to Hold from Underperform at Needham
Needham analyst Laura Martin upgraded Snap to Hold after its Q3 earnings beat, saying that based on its Q4 EBITDA guidance, she now expects the company to reach breakeven free cash flows in Q1 of 2020. The analyst notes that the company has "met its promise" to reduce costs and drive margin expansion, while its $1.1B convertible debt issuance in August has added to its balance sheet strength. Martin further cites Snap's improved revenue trajectory with a "growing number of 'always on' advertisers".

TODAY'S FREE FLY STORIES

JCDXF

JCDecaux

$0.00

(0.00%)

05:30
11/19/19
11/19
05:30
11/19/19
05:30
Initiation
JCDecaux initiated  »

JCDecaux initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$184.53

0.94 (0.51%)

, ABBV

AbbVie

$88.71

0.07 (0.08%)

05:29
11/19/19
11/19
05:29
11/19/19
05:29
Downgrade
Allergan, AbbVie rating change  »

UBS downgrades Allergan…

AGN

Allergan

$184.53

0.94 (0.51%)

ABBV

AbbVie

$88.71

0.07 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

ROK

Rockwell Automation

$197.64

-2.58 (-1.29%)

05:25
11/19/19
11/19
05:25
11/19/19
05:25
Downgrade
Rockwell Automation rating change  »

Rockwell Automation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

AGN

Allergan

$184.53

0.94 (0.51%)

05:24
11/19/19
11/19
05:24
11/19/19
05:24
Downgrade
Allergan rating change  »

Allergan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SEGXF

Segro

$0.00

(0.00%)

05:22
11/19/19
11/19
05:22
11/19/19
05:22
Downgrade
Segro rating change  »

Segro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JKS

JinkoSolar

$14.88

-0.01 (-0.07%)

05:22
11/19/19
11/19
05:22
11/19/19
05:22
Earnings
JinkoSolar reports Q3 EPS 86c, consensus 83c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 10

    Dec

TRQ

Turquoise Hill

$0.45

(0.00%)

05:20
11/19/19
11/19
05:20
11/19/19
05:20
Hot Stocks
Turquoise Hill notes Administrative Court proceedings in Mongolia »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRARY

Credit Agricole

$0.00

(0.00%)

05:18
11/19/19
11/19
05:18
11/19/19
05:18
Upgrade
Credit Agricole rating change  »

Credit Agricole upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$369.50

-2.05 (-0.55%)

05:16
11/19/19
11/19
05:16
11/19/19
05:16
Hot Stocks
Boeing: Air Astana intends to buy 30 737 MAX airplanes »

Air Astana intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMRN

Amarin

$22.63

-1.36 (-5.67%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Recommendations
Jefferies still expects Amarin shares to rise toward $30 »

Following the data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Dec

BB

BlackBerry

$5.28

-0.195 (-3.56%)

05:15
11/19/19
11/19
05:15
11/19/19
05:15
Hot Stocks
BlackBerry QNX technology to power Arrival intelligent, autonomous-ready EVs »

BlackBerry and electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 06

    Jan

ATRS

Antares Pharma

$4.28

0.12 (2.88%)

05:10
11/19/19
11/19
05:10
11/19/19
05:10
Hot Stocks
Antares Pharma enters into global development agreement with Idorsia »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XONE

ExOne

$7.00

-0.05 (-0.71%)

, ANSS

Ansys

$238.67

3.63 (1.54%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Hot Stocks
ExOne announces collaboration with Ansys »

ExOne (XONE) and ANSYS…

XONE

ExOne

$7.00

-0.05 (-0.71%)

ANSS

Ansys

$238.67

3.63 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 02

    Dec

  • 11

    Dec

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

, BBIO

BridgeBio

$29.06

0.8 (2.83%)

05:07
11/19/19
11/19
05:07
11/19/19
05:07
Recommendations
Eidos Therapeutics price target raised to $75 from $55 at Piper Jaffray »

Piper Jaffray analyst…

EIDX

Eidos Therapeutics

$55.16

8.58 (18.42%)

BBIO

BridgeBio

$29.06

0.8 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

PHAT

Phathom Pharmaceuticals

$24.88

-1.12 (-4.31%)

05:01
11/19/19
11/19
05:01
11/19/19
05:01
Initiation
Phathom Pharmaceuticals initiated  »

Phathom Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEG

Leggett & Platt

$53.54

0.18 (0.34%)

04:59
11/19/19
11/19
04:59
11/19/19
04:59
Downgrade
Leggett & Platt rating change  »

Leggett & Platt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CSL

Carlisle

$161.08

0.12 (0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Carlisle management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

KRP

Kimbell Royalty Partners

$14.18

0.19 (1.36%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Kimbell Royalty Partners management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

SU

Suncor

$31.84

-0.64 (-1.97%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Suncor management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

ASML

ASML

$273.38

-1.35 (-0.49%)

, ERIC

Ericsson

$9.10

-0.04 (-0.44%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
JPMorgan to hold a conference »

Global TMT…

ASML

ASML

$273.38

-1.35 (-0.49%)

ERIC

Ericsson

$9.10

-0.04 (-0.44%)

IMAX

Imax

$20.88

-0.19 (-0.90%)

SIMO

Silicon Motion

$42.65

0.03 (0.07%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 06

    Jan

ACCO

Acco Brands

$9.42

0.035 (0.37%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Acco Brands management to meet with Barrington »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Stephens business services analyst to hold a group luncheon »

Group Luncheon Meeting to…

CSGS

CSG

$57.54

0.54 (0.95%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
CSG management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

04:55
11/19/19
11/19
04:55
11/19/19
04:55
General news
Breaking General news story  »

8-Week Bill Announcement…

ADM

Archer Daniels

$42.84

-0.03 (-0.07%)

04:55
11/19/19
11/19
04:55
11/19/19
04:55
Conference/Events
Archer Daniels management to meet with Buckingham »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.